MYFEMBREE
Identification of Myfembree
| No description |
Google image searchProduct monograph
Active ingredients
relugolix, 40 MG
estradiol, 1 MG
norethindrone acetate, 0.5 MG
DIN: 02541742
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: SUMITOMO PHARMA SWITZERLAND GMBH
Date: 29-JAN-2024
ATC:
- H01 — PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES (ATC, ATC/DDD, )
- H01C — HYPOTHALAMIC HORMONES (ATC, ATC/DDD)
- H01CC — Anti-gonadotropin-releasing hormones (ATC, ATC/DDD)
- H01CC54 — RELUGOLIX, ESTRADIOL AND NORETHISTERONE (ATC/DDD)
Reference brand drug: Myfembree
